| Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice P Fickert, A Fuchsbichler, M Wagner, G Zollner, A Kaser, H Tilg, R Krause, ... Gastroenterology 127 (1), 261-274, 2004 | 551 | 2004 |
| Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases G Zollner, P Fickert, R Zenz, A Fuchsbichler, C Stumptner, L Kenner, ... Hepatology 33 (3), 633-646, 2001 | 467 | 2001 |
| CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice M Wagner, E Halilbasic, HU Marschall, G Zollner, P Fickert, C Langner, ... Hepatology 42 (2), 420-430, 2005 | 403 | 2005 |
| A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis P Fickert, U Stöger, A Fuchsbichler, T Moustafa, HU Marschall, ... The American journal of pathology 171 (2), 525-536, 2007 | 393 | 2007 |
| Bile acids as regulators of hepatic lipid and glucose metabolism M Trauner, T Claudel, P Fickert, T Moustafa, M Wagner Digestive diseases 28 (1), 220-224, 2010 | 370 | 2010 |
| Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans HU Marschall, M Wagner, G Zollner, P Fickert, U Diczfalusy, J Gumhold, ... Gastroenterology 129 (2), 476-485, 2005 | 370 | 2005 |
| 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice P Fickert, M Wagner, HU Marschall, A Fuchsbichler, G Zollner, ... Gastroenterology 130 (2), 465-481, 2006 | 344 | 2006 |
| Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles P Fickert, G Zollner, A Fuchsbichler, C Stumptner, AH Weiglein, ... Gastroenterology 123 (4), 1238-1251, 2002 | 339 | 2002 |
| Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis G Zollner, P Fickert, D Silbert, A Fuchsbichler, HU Marschall, K Zatloukal, ... Journal of hepatology 38 (6), 717-727, 2003 | 338 | 2003 |
| Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver P Fickert, G Zollner, A Fuchsbichler, C Stumptner, C Pojer, R Zenz, ... Gastroenterology 121 (1), 170-183, 2001 | 335 | 2001 |
| Inflammationinduced cholestasis M Trauner, P Fickert, RE Stauber Journal of gastroenterology and hepatology 14 (10), 946-959, 1999 | 317 | 1999 |
| Mdr2 (Abcb4)-/-mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro-and antifibrogenic genes Y Popov, E Patsenker, P Fickert, M Trauner, D Schuppan Journal of hepatology 43 (6), 1045-1054, 2005 | 304 | 2005 |
| Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice M Wagner, P Fickert, G Zollner, A Fuchsbichler, D Silbert, O Tsybrovskyy, ... Gastroenterology 125 (3), 825-838, 2003 | 302 | 2003 |
| Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis A Geier, P Fickert, M Trauner Nature clinical practice Gastroenterology & hepatology 3 (10), 574-585, 2006 | 285 | 2006 |
| Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical … L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ... Endoscopy 49 (06), 588-608, 2017 | 273 | 2017 |
| norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis P Fickert, GM Hirschfield, G Denk, HU Marschall, I Altorjay, M Färkkilä, ... Journal of hepatology 67 (3), 549-558, 2017 | 268 | 2017 |
| MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes M Trauner, P Fickert, M Wagner Seminars in liver disease 27 (01), 077-098, 2007 | 254 | 2007 |
| Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in theMdr2−/−(Abcb4−/−) mouse cholangiopathy model by promoting biliary HCOSymboloutput A Baghdasaryan, T Claudel, J Gumhold, D Silbert, L Adorini, A Roda, ... Hepatology 54 (4), 1303-1312, 2011 | 243 | 2011 |
| Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine G Zollner, P Fickert, A Fuchsbichler, D Silbert, M Wagner, S Arbeiter, ... Journal of hepatology 39 (4), 480-488, 2003 | 236 | 2003 |
| Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis M Trauner, M Wagner, P Fickert, G Zollner Journal of clinical gastroenterology 39 (4), S111-S124, 2005 | 224 | 2005 |
